Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation-Reference-Cited by-同舟云学术

Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

Published:1999-05 Issue:9166 Volume:353 Page:1755-1759
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sykes Megan,Preffer Frederic,McAfee Steven,Saidman Susan L,Weymouth Dina,Andrews David M,Colby Christine,Sackstein Robert,Sachs David H,Spitzer Thomas R

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's;Ratanatharathorn;Lymphoma. Blood,1994

2. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's;Verdonck;Lymphoma. Blood,1997

3. Graft-versus-leukemia effect in MHC-compatible and -incompatible allogeneic bone marrow transplantation of radiation-induced, leukemia-bearing mice;Aizawa;Transplantation,1991

4. Genetic analysis of the anti-leukemic effect of mixed allogeneic bone marrow transplantation;Sykes;Transplant Proc,1989

5. Histoincompatible bone marrow transplants in humans;Clift;Annu Rev Immunol,1987

Cited by 349 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerance in intestinal transplantation;Human Immunology;2024-05

2. Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma;Frontiers in Oncology;2023-07-20

3. Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity;Immunotherapy Advances;2023-01-01

4. Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial;Journal of Clinical Oncology;2021-10-20

5. Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3+ T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome Patients;Frontiers in Oncology;2021-10-13